通貨 / PFE
PFE: Pfizer Inc
25.36
USD
0.22
(0.86%)
PFEの今日の為替レートは、-0.86%変化しました。日中、通貨は1あたり25.34の安値と25.63の高値で取引されました。
Pfizer Incダイナミクスに従います。リアルタイムの相場は、市場の変化に迅速に対応するのに役立ちます。 異なる時間枠に切り替えることで、為替レートの傾向とダイナミクスを分、時間、日、週、月単位で監視できます。この情報を使用して、市場の変化を予測し、十分な情報に基づいて取引を決定してください。
- M5
- M15
- M30
- H1
- H4
- D1
- W1
- MN
PFE News
- Seeking Alpha Building A $100,000 Dividend Portfolio: Maximizing SCHD With July High-Yield Stocks (SCHD)
- Benzinga Pfizer Faces $1 Billion IRA Reform Hit, Analysts Call Outlook Flat - Pfizer (NYSE:PFE)
- Benzinga Is Bristol-Myers Squibb Still An Undervalued Biopharma Play? - Bristol-Myers Squibb (NYSE:BMY)
- Seeking Alpha AnaptysBio: Potential Promise, But Some Cause For Skepticism (NASDAQ:ANAB)
- Investing GSK seeks FDA nod for expanded use of RSV vaccine in adults
- Investing BridgeBio Pharma stock initiated with Buy rating at Jefferies on Attruby potential
- Seeking Alpha Why Novartis Stock Is Still A 'Buy' After 15% Surge (NYSE:NVS)
- Seeking Alpha Arvinas: A Potential 'Sum Of The Parts' Story (NASDAQ:ARVN)
- Seeking Alpha Dogs Of The S&P 500: 14 Ideal 'Safer' July Dividend Buys
- Benzinga Pfizer, Sanofi Find Relief As Delaware Top Court Rejects Zantac Expert Testimony - Pfizer (NYSE:PFE), Sanofi (NASDAQ:SNY)
- Benzinga Trump Threatens 200% Pharma Tariffs, But Analyst Says This Stock Is Immune And Expected To 'Benefit' From Levies - AbbVie (NYSE:ABBV), Amgen (NASDAQ:AMGN)
- Investing Relay Therapeutics CEO Patel sells $219k in shares
- Benzinga Pfizer, Astellas Report Xtandi Survival Win In Prostate Cancer Study - Pfizer (NYSE:PFE)
- Benzinga An Investor Wonders Why Trump's Tariffs Aren't Shaking The Markets. 'Does Wall Street Simply Not Care About The Economy Anymore?' - Amgen (NASDAQ:AMGN), Amazon.com (NASDAQ:AMZN)
- Benzinga FDA Grants Complete Approval To Moderna's COVID-19 Vaccine For Children As Young As 6 Months - Moderna (NASDAQ:MRNA)
- Investing Moderna stock rating reiterated at Buy by Brookline Capital Markets
- Investing Pfizer and BioNTech appeal UK ruling on Moderna COVID vaccine patent
- Seeking Alpha Cogent: Positive Data In NonAdvSM Bodes Well For 2nd Half AdvSM Treatment Results (COGT)
- TheStreet One Washington move could shake Big Pharma to its core
- Investing Factbox-Major deals involving U.S. drugmakers and biotechs over the past decade
- Investing EnergyX to acquire 35,000-acre lithium deposit from Pantera for A$40m
- GuruFocus Trump Unleashes Tariff Tsunami: Copper at 50%, Pharma Faces 200% -- Markets Rattle
- Investing Arvinas CEO John Houston to retire after successor is named, will remain board chair
- Investing Pfizer restructures executive team as reputation chief departs - Bloomberg
1日のレンジ
25.34
25.63
1年のレンジ
20.91
31.32
- 以前の終値
- 25.64
- 始値
- 25.58
- 買値
- 25.36
- 買値
- 25.66
- 安値
- 25.34
- 高値
- 25.63
- 出来高
- 23.437 K
- 1日の変化
- -0.86%
- 1ヶ月の変化
- 4.41%
- 6ヶ月の変化
- -3.57%
- 1年の変化
- -17.45%
15 7月, 火曜日
11:00
ALL
- 実際
- 期待
- 前
12:30
USD
- 実際
- 期待
- -0.3%
- 前
- 0.1%
12:30
USD
- 実際
- 期待
- 0.2%
- 前
- 0.1%
12:30
USD
- 実際
- 期待
- 2.4%
- 前
- 2.4%
12:30
USD
- 実際
- 期待
- 2.7%
- 前
- 2.8%
12:30
USD
- 実際
- 期待
- 321.516
- 前
- 321.465
12:30
USD
- 実際
- 期待
- 327.606
- 前
- 326.854
12:30
USD
- 実際
- 期待
- 0.1%
- 前
- 0.3%
12:30
USD
- 実際
- 期待
- 前
- 0.2%
12:30
USD
- 実際
- 期待
- 前
- 0.2%
12:30
USD
- 実際
- 期待
- 320.395
- 前
- 320.580
12:30
USD
- 実際
- 期待
- 前
- 327.509
12:30
USD
- 実際
- 期待
- 2.2
- 前
- -16.0
13:15
USD
- 実際
- 期待
- 前
15:00
USD
- 実際
- 期待
- 0.2%
- 前
- 0.2%
16:45
USD
- 実際
- 期待
- 前